Avaí Bio, Inc. AVAI
0.09 USD -0.01 (-12.00%)
Nov 5, 2026, 1:47 PM EST
0.094 Day range 0.10
0.083 52-week range 0.80
- YTD
- -76.84%
- 1 year
- -77.89%
- Market cap
- 13.54M
- YTD return
- -76.84%
- 1-year return
- -77.89%
- Volume
- 25.20K
- Avg volume
- 90.07K
- Open
- 0.10
- Previous close
- 0.10
- Day's range
- 0.094 – 0.10
- 52-week range
- 0.083 – 0.80
2Y -0.2378 (-73.17%)
News
Avaí Bio and Austrianova Announce Publication in Frontiers in Aging Journal Highlighting Novel Cell Encapsulation-Based Approach to Sustained Klotho Delivery 
Avant Brands Reports Q3 2026 Results Highlighted by Positive Net Income and 51% Growth in Recreational Revenue 
Avaí Bio and Austrianova Hold First Joint Steering Committee Meeting with Ospedale San Raffaele for Diabetes Cell Therapy Program 
Avaí Bio and Austrianova Successfully Encapsulate GMP-Quality Klotho-Producing Cells, Achieve Robust Klotho Secretion 
Avaí Bio and Austrianova Present Encapsulated Cell Approach to Sustained α-Klotho Delivery at 2026 Klotho Conference 
Avaí Bio and Austrianova Complete Adventitious Agent Testing of Master Cell Bank, Establish Working Cell Bank for α-Klotho Anti-Aging Therapy 
Avant Brands Completes EU GMP Audit at Flowr Facility 
Avaí Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes 
Avant Brands Completes Major LED Lighting Retrofit at its 80,000 Sq Ft Flowr Facility, Delivering Significant Energy Savings & Production Gains 
Avaí Bio and Austrianova Reach Agreement for Insulin-Producing Cells with Internationally Acclaimed Partner to Advance Diabetes Therapy
Your note
Sign in to keep a note on AVAI — it syncs with the Stock Master app.